• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Optical imaging spectroscopy for rapid, primary screening of SARS-CoV-2: a proof of concept

tetano

Editor, Senior Moderator
Sci Rep


. 2022 Feb 18;12(1):2356.
doi: 10.1038/s41598-022-06393-3.
Optical imaging spectroscopy for rapid, primary screening of SARS-CoV-2: a proof of concept


Emilio Gomez-Gonzalez[SUP] 1 2 [/SUP], Alejandro Barriga-Rivera[SUP] 3 4 [/SUP], Beatriz Fernandez-Muñoz[SUP] 5 [/SUP], Jose Manuel Navas-Garcia[SUP] 6 [/SUP], Isabel Fernandez-Lizaranzu[SUP] 3 7 [/SUP], Francisco Javier Munoz-Gonzalez[SUP] 3 [/SUP], Ruben Parrilla-Giraldez[SUP] 8 [/SUP], Desiree Requena-Lancharro[SUP] 3 [/SUP], Pedro Gil-Gamboa[SUP] 3 [/SUP], Cristina Rosell-Valle[SUP] 7 5 [/SUP], Carmen Gomez-Gonzalez[SUP] 9 10 [/SUP], Maria Jose Mayorga-Buiza[SUP] 7 11 12 [/SUP], Maria Martin-Lopez[SUP] 7 5 [/SUP], Olga Muñoz[SUP] 13 [/SUP], Juan Carlos Gomez-Martin[SUP] 13 [/SUP], Maria Isabel Relimpio-Lopez[SUP] 12 14 15 [/SUP], Jesus Aceituno-Castro[SUP] 13 16 [/SUP], Manuel A Perales-Esteve[SUP] 17 [/SUP], Antonio Puppo-Moreno[SUP] 9 10 [/SUP], Francisco Jose Garcia-Cozar[SUP] 18 [/SUP], Lucia Olvera-Collantes[SUP] 19 [/SUP], Raquel Gomez-Diaz[SUP] 7 [/SUP], Silvia de Los Santos-Trigo[SUP] 20 [/SUP], Monserrat Huguet-Carrasco[SUP] 21 [/SUP], Manuel Rey[SUP] 22 [/SUP], Emilia Gomez[SUP] 23 [/SUP], Rosario Sanchez-Pernaute[SUP] 5 [/SUP], Javier Padillo-Ruiz[SUP] 7 12 24 [/SUP], Javier Marquez-Rivas[SUP] 7 12 25 26 [/SUP]



Affiliations

Abstract

Effective testing is essential to control the coronavirus disease 2019 (COVID-19) transmission. Here we report a-proof-of-concept study on hyperspectral image analysis in the visible and near-infrared range for primary screening at the point-of-care of SARS-CoV-2. We apply spectral feature descriptors, partial least square-discriminant analysis, and artificial intelligence to extract information from optical diffuse reflectance measurements from 5 µL fluid samples at pixel, droplet, and patient levels. We discern preparations of engineered lentiviral particles pseudotyped with the spike protein of the SARS-CoV-2 from those with the G protein of the vesicular stomatitis virus in saline solution and artificial saliva. We report a quantitative analysis of 72 samples of nasopharyngeal exudate in a range of SARS-CoV-2 viral loads, and a descriptive study of another 32 fresh human saliva samples. Sensitivity for classification of exudates was 100% with peak specificity of 87.5% for discernment from PCR-negative but symptomatic cases. Proposed technology is reagent-free, fast, and scalable, and could substantially reduce the number of molecular tests currently required for COVID-19 mass screening strategies even in resource-limited settings.
 
Back
Top Bottom